This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Wenkerl, M A. Articles by de Wolff, F A Search for Related Content PubMed PubMed Citation Articles by Wenkerl, M A. Articles by de Wolff, F A Social Bookmarking                         What's this?

Metabolic capacity and interindividual variation in toxicokinetics of styrene in volunteers

S Kei

A C Monster

Coronel Institute, Academic Medical Center, University ofAmsterdam, Amsterdam, The Netherlands

F A de Wolff

Toxicology Laboratory, Leiden University Medical Center, Leiden, The Netherlands

The aim of the present study was to assess the interindividual variation in styrene toxicokinetics and to correlate this variation with the individual metabolic capacity for cytochromeP450 (CYP), CYP2E1, CYP1A2 and CYP2D6. Twenty male volunteers were exposed on separate occasions to 104±3 and 360 ± 20 mg/m³ of styrene for 1 h while performing 50 W physical exercise on a bicycle ergometer. Styrene concentrations in blood and mandelic (MA) and phenylglyoxylic acid (PGA) in urine were measured. The metabolic capacity was assessed by phenotyping with chlorzoxazone (CYP2El), caffeine (CYP1A2), dextromethorphan (CYP2D6) and antipyrine (CYP450). In addition, for the main styrene-metabolising enzyme, CYP2E1, genotyping for the genetic polymorphisms of the gene was performed. The average pulmonary retention of styrene was 62 ± 7% at both exposure concentrations, and the 24-h excretion of MA and PGA accounted for 58% of the dose at both concentrations. The interindividual variation in styrene kinetics ranged from 19% for the terminal half-life (t_1/2,ß) of styrene to 41% for the cumulative excretion of MA and PGA. However, no correlation between the apparent blood clearance of styrene (CL_app), t_1/2,ß of styrene or excretion of MA and PGA on one hand, and the individual metabolic capacity on the other hand was found. Although other explanations cannot be excluded, this lack of correlation might be due to the high apparent blood clearance (1.4 1/ min) of styrene, indicating that styrene metabolism is liver–blood-flow-dependent.

Key Words: styrene • mandelic acid • phenylglyoxylic acid • cytochrome P450 • interindividual variation

Human & Experimental Toxicology, Vol. 20, No. 5, 221-228 (2001)
DOI: 10.1191/096032701678227712


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?